Fig. 4From: The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort studyRisks of clinical events of patients receiving different NOACs compared to “AP only”. AP = anti-platelet agents; HR = hazard ratio; ICH = intra-cranial hemorrhage; CI = confidence interval; NOACs = non–vitamin K antagonist oral anticoagulantsBack to article page